在服用尼古丁胺胺单核酸 (NMN) 的患者中改善体力表现参数:随机对照试验的系统审查
Jimmy Wen1, Burhaan Syed2, Solomon Kim3
1Physical Medicine and Rehabilitation, California Northstate University College of Medicine, Elk Grove, USA.
尼古丁胺胺单核酸 (NMN) 补充剂显示了改善身体表现的潜力,研究表明它耐受性良好,安全使用. 需要进一步的研究来证实显著的性能提升.
科学领域:
- 代谢和衰老研究 研究
- 细胞生物学和生物化学
背景情况:
- 尼古丁胺胺氨基二核酸 (NAD+) 是细胞过程中必不可少的辅酶.
- 随着年龄的增长,NAD+水平下降,影响细胞功能.
- 尼古丁胺胺单核酸 (NMN) 是NAD+的直接前体.
研究的目的:
- 系统地审查NMN补充对身体表现的影响.
- 评估NMN补充剂的安全性和耐受性.
主要方法:
- 按照PRISMA指南进行随机对照试验 (RCT) 的系统审查.
- 在四个数据库中搜索相关研究.
- 包括10项研究,437名参与者 (平均年龄58.0岁).
- 分析了关于NMN剂量,干预持续时间和身体表现结果的数据.
主要成果:
- 在4-12周内,NMN剂量从150至1200毫克/天不等.
- 平均握力从29.9公斤增加到30.5公斤.
- 平均骨质量指数保持稳定,为7.4kg/m2.
- 补充NMN证明了身体表现的非显著改善.
- 没有报告严重的副作用;副作用与NMN无关.
结论:
- NMN耐受性良好,安全,没有观察到严重的不良反应.
- 补充NMN显示了改善身体表现的趋势,尽管在统计学上并不显著.
- 需要进一步的研究来确定NMN在增强身体表现方面的有效性.
更多相关视频
08:19Transfer of Manipulated Tumor-associated Neutrophils into Tumor-Bearing Mice to Study their Angiogenic Potential In Vivo
Published on: July 20, 2019
06:38In Ovo Feeding of Commercial Broiler Eggs: An Accurate and Reproducible Method to Affect Muscle Development and Growth
Published on: September 20, 2021
相关概念视频
Drugs Acting on Autonomic Ganglia: Stimulants
Ganglionic stimulants activate NM nicotinic receptors in autonomic ganglia, falling into two categories: nicotine mimetics [e.g., lobeline, dimethylpiperazine, tetramethylammonium] and muscarinic receptor agonists [e.g., muscarine, methacholine]. The first category's action is rapid and blocked by nicotinic receptor antagonists, while the second category's action is delayed and blocked by atropine-like agents. Nicotine, an alkaloid, affects the heart rate by stimulating...
Antianginal Drugs: Nitrates and β-Blockers
Organic nitrates, such as nitroglycerin, play a pivotal role. Once metabolized, they liberate nitric oxide, a molecular marvel. Nitric oxide triggers guanylyl cyclase and augments cGMP production. This biochemical cascade orchestrates the relaxation of vascular smooth muscles, ushering in vasodilation and enhancing coronary blood flow....
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
Medical History
Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
Assessment of the Cardiovascular System I: Subjective Data
Initial Enquiry
Ask the patient about their primary concern and thoroughly explore all reported symptoms.
Medical History
Investigate past illnesses affecting the cardiovascular system, such as angina, anemia, rheumatic fever, congenital heart disease, stroke, thrombophlebitis, dysrhythmias, varicosities
Inquire about symptoms...
Role of Reduced Coenzymes NADH and FADH₂
